These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24742370)

  • 41. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF; Poza JJ
    Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
    Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
    J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.
    Bondon-Guitton E; Perez-Lloret S; Bagheri H; Brefel C; Rascol O; Montastruc JL
    Mov Disord; 2011 Oct; 26(12):2226-31. PubMed ID: 21674626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with Parkinson's disease.
    Tsujimura A; Yamamoto Y; Sakoda S; Okuda H; Yamamoto K; Fukuhara S; Yoshioka I; Kiuchi H; Takao T; Miyagawa Y; Nonomura N
    Int J Urol; 2014 Jan; 21(1):69-73. PubMed ID: 23659545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral and genital pain syndromes in Parkinson's disease.
    Ford B; Louis ED; Greene P; Fahn S
    Mov Disord; 1996 Jul; 11(4):421-6. PubMed ID: 8813222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Elgh E; Forsgren L
    Mov Disord; 2011 Oct; 26(12):2183-9. PubMed ID: 21661051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.
    Dick FD; De Palma G; Ahmadi A; Scott NW; Prescott GJ; Bennett J; Semple S; Dick S; Counsell C; Mozzoni P; Haites N; Wettinger SB; Mutti A; Otelea M; Seaton A; Söderkvist P; Felice A;
    Occup Environ Med; 2007 Oct; 64(10):666-72. PubMed ID: 17332139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular parkinsonism: what makes it different?
    Gupta D; Kuruvilla A
    Postgrad Med J; 2011 Dec; 87(1034):829-36. PubMed ID: 22121251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parkinsonism following neuroleptic exposure: A double-hit hypothesis?
    Erro R; Bhatia KP; Tinazzi M
    Mov Disord; 2015 May; 30(6):780-5. PubMed ID: 25801826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using accelerometer as a diagnostic tool to detect drug-induced parkinsonism (DIP) secondary to first-generation anti-psychotic medications.
    Trisno R; Nair P; Martin D; Baghini MS; Chung H; Pendharkar G; Kulkarni J
    Australas Psychiatry; 2020 Jun; 28(3):348-353. PubMed ID: 32093499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.
    Durcan R; Wiblin L; Lawson RA; Khoo TK; Yarnall AJ; Duncan GW; Brooks DJ; Pavese N; Burn DJ;
    Eur J Neurol; 2019 Jul; 26(7):979-985. PubMed ID: 30706593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of Motor and Non-Motor Features in Medication-Naïve Parkinsonism.
    Jain S; Park SY; Comer D
    Neuroepidemiology; 2015; 45(1):59-69. PubMed ID: 26227734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
    Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
    Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs.
    Playford ED; Britton TC; Thompson PD; Brooks DJ; Findley LJ; Marsden CD
    J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):487-9. PubMed ID: 7738563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.
    Shaikh AG
    Neurol Sci; 2017 May; 38(5):855-863. PubMed ID: 28229302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trajectories of prediagnostic functioning in Parkinson's disease.
    Darweesh SK; Verlinden VJ; Stricker BH; Hofman A; Koudstaal PJ; Ikram MA
    Brain; 2017 Feb; 140(2):429-441. PubMed ID: 28082300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson's Disease: A Retrospective Study.
    Rodríguez-Violante M; de Saráchaga AJ; Cervantes-Arriaga A; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
    J Parkinsons Dis; 2016; 6(1):183-90. PubMed ID: 26683422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.